Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2001-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which combination chemotherapy regimen is more effective for treating
extensive-stage small cell lung cancer.
PURPOSE: Randomized phase II trial to compare the effectiveness of combining topotecan and
paclitaxel with that of combining etoposide and cisplatin in treating patients who have
extensive-stage small cell lung cancer.